Covapin Inhibition of Acquaporina-9 as new hyper-inflammation therapy

  • Funded by Ministry of Education, University and Research Italy
  • Total publications:3 publications

Grant number: FISR2020IP_04051

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $59,443.23
  • Funder

    Ministry of Education, University and Research Italy
  • Principal Investigator

    N/A

  • Research Location

    Italy
  • Lead Research Institution

    N/A
  • Research Priority Alignment

    N/A
  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Clinical trial (unspecified trial phase)

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Selective Blockade of Two Aquaporin Channels, AQP3 and AQP9, Impairs Human Leukocyte Migration.

Characterization of the Aquaporin-9 Inhibitor RG100204 In Vitro and in db/db Mice.

Aquaporins Are One of the Critical Factors in the Disruption of the Skin Barrier in Inflammatory Skin Diseases.